Latest Case Studies

Immunogenicity biomarkers in individuals previously infected with COVID-19 were used to evaluate vaccines in preclinical and clinical trials.

A specific autoimmune indication was identified for a novel therapy using patient donor biospecimens.

A prospective, longitudinal study using in-home collected biospecimens identified a panel of predictive biomarkers.

Confirming preclinical pharmacology in whole blood from MS patients.

As an X-linked disorder, Duchenne’s muscular dystrophy (DMD) primarily affects males, with an incidence of one in every…